Clinical trial
Raloxifene for Women With Alzheimer's Disease
NCT00368459 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00368459 |
|---|---|
| Title | Raloxifene for Women With Alzheimer's Disease |
| Official title | Raloxifene in Women With AD: Randomized Controlled Trial |
| Lead sponsor | Stanford University, Other |
| Collaborators | Kaiser Permanente Indiana University Southern Illinois University |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Alzheimer Disease |
| Intervention type | Drug |
| Interventions | raloxifene, Placebo |
| Enrollment | 42 |
| Start date | Aug 1, 2006 |
| Primary completion | Mar 1, 2011 |
| Completion | Jan 1, 2012 |
| First posted | Aug 24, 2006 |
| Last update posted | Apr 2, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: